Abiopharma

🔍 Moller Andrew James (Executive)

Company: CONMED Corp (CNMD)

Report Date: 2026-03-02

Detailed Transactions and Holdings:

• Acquired 5,896 shares of RSUs (Restricted Stock Units) (Derivative)
  Date: 2026-03-02 | Code: A | Expires: 2036-03-02 | equity_swap_involved: 0 | shares_owned_after: 5,896.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.